The acceptance meeting for the 23-valent pneumococcal polysaccharide vaccine industrialization project was successfully held.

Release date:

2020-10-26

Author:

Source:


Abstract

On October 19, 2020, the project titled “Industrialization of the 23-valent Pneumococcal Polysaccharide Vaccine (Bulk Production and Fill‑and‑Finish)” — a special initiative under the National Development and Reform Commission’s 2014 program for the development of protein‑based biologics and vaccines — was reviewed and accepted at a meeting chaired by the Beijing Municipal Development and Reform Commission. The meeting was attended by more than 15 participants, including representatives from the Beijing Municipal Development and Reform Commission, the Beijing Center for Disease Control and Prevention, technical and financial review experts, and the project leader. Following presentations, document reviews, expert questioning and clarification, and an on‑site inspection of the production facility, the expert panel unanimously concluded that the project had successfully achieved all its planned objectives and met the acceptance criteria.

On October 19, 2020, the project undertaken by Beijing Minhai Biotechnology Co., Ltd. under the National Development and Reform Commission’s 2014 program… Annual Special Project for the Development of Protein-Based Biologics and Vaccines – “23” An acceptance meeting for the “Industrialization of Pneumococcal Polysaccharide Vaccine (Bulk Production and Fill‑and‑Finish)” project was held under the auspices of the Beijing Municipal Development and Reform Commission. The meeting was attended by more than 15 participants, including representatives from the Beijing Municipal Development and Reform Commission, the Beijing Center for Disease Control and Prevention, technical and financial review experts, and the project leader. Following a project presentation, document review, expert questioning and clarification, and an on-site inspection of the production facility, the expert panel unanimously concluded that the project had successfully achieved all its planned objectives, met the acceptance criteria, and recommended approval of the project’s completion.

Recommended Reading


Batch Release Status of the Company’s Products in 2026


The company's product 2026 annual batch issuance situation is as follows:

2026-07-23

Good News | Another Star Award! Minhai Biotechnology has once again been recognized as a “Five-Star Green Credit Enterprise” in Daxing District.


Recently, the Daxing District Bureau of Ecology and Environment completed the fifth round of corporate green credit rating for 2025 and officially released the “2025 Daxing District Green Credit Enterprise Directory.” Thanks to its robust environmental management system, consistent compliance performance, and outstanding achievements in energy conservation and carbon reduction, Minhai Biotechnology has once again been awarded the region’s highest “Five-Star Green Credit Enterprise” rating. The Daxing District’s corporate green credit assessment covers five major categories—environmental compliance, pollution control and emission reduction, low‑carbon circular economy, scientific management, and social contribution—comprising a total of 30 sub‑indicators. With stringent standards and comprehensive evaluation, the program employs dynamic review and a veto‑based mechanism, with the Five‑Star rating representing the highest level of ecological credit in the district.

2026-07-15

Good News | The Party Branch of Minhai Biotechnology has been awarded the “Two Excellences and One Pioneer” honor in Beijing’s emerging sectors, as well as a park‑level commendation.


Recently, Beijing held a grand commendation conference for the “Two Excellences and One Pioneer” initiative in emerging sectors. The “Two New” Working Committee of the CPC Beijing Municipal Committee recognized outstanding Communist Party members, exemplary Party affairs workers, and advanced primary-level Party organizations across the city’s emerging fields. The Party branch of Beijing Minhai Biotechnology Co., Ltd. was honored as an advanced primary-level Party organization in Beijing’s emerging sectors. Wu Chengyu, the branch secretary, attended the ceremony in person to receive the award. At the event, the Party flag flew proudly amid a solemn atmosphere, and the awardees, adorned with honor ribbons and holding certificates and medals, jointly witnessed this prestigious municipal recognition. This designation as an advanced primary-level Party organization at the municipal level represents the “Two New” Working Committee of the Municipal Party Committee’s high appraisal of the Minhai Biotechnology Party branch.

2026-07-09